PIH26 COST EFFECTIVENESS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS AMONG EXTREME PRETERM INFANTS (29 WEEKS OF GESTATIONAL AGE) AT THE SOCIAL SECURITY MEXICAN INSTI... by Paladio Hernández, J.Á., Lagunas-Quiroz, J.I., Matías-Juan, N.A.

Get full text

EE433 BUDGET IMPACT ANALYSIS OF GLATIRAMER ACETATE 40MG (DOXELEV®) IN THE TREATMENT OF RELAPSING–REMITTING MULTIPLE SCLEROSIS IN IN MEXICO by Domínguez-Cruces, C., Sanchez, P., Santillán-Montelongo, E., Martínez-Alvarado, I., Godina-Ortiz, B.A., Paladio Hernández, J.Á.

Get full text

PIN39 ECONOMIC EVALUATION OF THE NATIONAL AIDS PLAN RECOMMENDED GUIDELINES FOR COFORMULATED INITIAL ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS IN MEXICO IN 2018 by Paladio Hernández, J.Á., Leal-González, M., Devars-Cleren, E.A., Godina-Ortiz, B.A., Vera-Rendón, P.

Get full text

PCN124 BUDGET IMPACT ANALYSIS OF IMMUNOTHERAPY AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AT MEXICO´S NATIONAL INSTITUTE OF CANCER by Barrón-Barrón, F., Meneses-García, A.A., Rivera, L.M., de la Garza-Salazar, J., Cardona, A.F., Arrieta, O.G., Chávez Millan, F., Palafox Torres, D., Paladio Hernández, J.Á.

Get full text

PIN11 Budget IMPACT of the National AIDS PLAN Recommended Guidelines for Preferent NO Coformulated Initial Antiretroviral Therapy in Naïve HIV-Infected Adults in Mexico in 2020 by Leal-González, M., Devars-Cleren, E.A., Godina-Ortiz, B.A., Vera-Rendón, P., Paladio Hernández, J.Á.

Get full text

P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at MX's National Institute of Cancer by Tirado, L.A. Ramírez, Barrón, F., Barron, L. Zatarain, Álvarez, M.P. Peralta, Meneses-García, A.A., Ruíz-Godoy, L.M., De La Garza Salazar, J., Torres, D.I. Palafox, Millan, M.F. Chávez, Hernández, J.Á. Paladio, Cardona, A.F., Arrieta, O.

Get full text

PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEAR... by Leal-González, M., Devars-Cleren, E.A., Paladio Hernández, J.Á., Barrera-Balderas, L.T., Vera-Rendón, P., Godina-Ortiz, B.A.

Get full text

PIN7 ECONOMIC EVALUATION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (GENVOYA®) AS A COMPLETE TREATMENT REGIMEN FOR HIV-1 INFECTION IN ADULTS WHO ARE ANTIRETROVI... by Paladio Hernández, J.Á., Leal-González, M., Devars-Cleren, E.A., Barrera-Balderas, L.T., Vera-Rendón, P., Godina-Ortiz, B.A.

Get full text

PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal by Panopoulou, P, Garcia-Contreras, F, Paladio-Hernandez, J.A, Huerta, J.L, Gonzalez Pier, E

Get full text

PCN10 - ECONOMIC IMPACT OF MEDICATION ERRORS DETECTED IN ONCOLOGIC INPATIENTS AND OUTPATIENTS IN A MEXICAN HOSPITAL by Morales Perez, M., Paladio-Hernandez, J.A., Luna Mendoza, D., Paredes-Garcia, P., Munguia Juarez, L., Sanchez Rodriguez, I., Lopez-Luis, J., Hernandez-Martinez, J., Ramirez-Padilla, L., Diaz-Rosales, S., Ponce-Rodriguez, M.

Get full text